The future direction of imaging in prostate cancer: MRI with or without contrast injection.

Today, the accessibility to MRI for early detection of PCa is a priority. Results from prospective, multicenter, multireader, and paired validation studies are needed to provide evidence supporting its role in the clinical practice.